Human CD4+ T-cell clones specific for pertussis toxin and other Bordetella pertussis antigens have been tested for their cytotoxic activity, lymphokine production, and capacity to induce immunoglobulin synthesis. Clones specific for the ST subunit of pertussis toxin were cytotoxic for autologous Epstein-Barr virus-transformed B cells, which had been pulsed with the native antigen, the recombinant S1 subunit of pertussis toxin, or synthetic peptides derived from the S1 amino acid sequence. The killing of antigen-pulsed target cells was class II restricted. All of the T-cell clones produced mostly interleukin-2 and gamma interferon and assisted allogeneic B cells in the production of immunoglobulins M and G but not immunoglobulin E. The potential in vivo role of the cytotoxic activity of these clones is discussed.
Traditionally, immunity against bacterial infections has been investigated by studying the humoral response to whole bacteria or individual antigens. Recent studies have shown that cellular immunity may also have a relevant role, especially in instances where bacteria invade eukaryotic cells. For instance, L3T4+ T lymphocytes specific for Listeria monocytogenes have been shown to confer adoptive protection against listeriosis (19) , whereas in mycobacteria both class I-and class II-restricted T cells have been involved in antibacterial immunity (16) . Usually, class I-restricted T lymphocytes kill the cells that present the antigen on their surface, whereas class II-restricted T cells provide help to B lymphocytes for immunoglobulin synthesis. However, a number of exceptions to this rule have been already reported, and CD4+ T cells with cytotoxic properties have been described (16, 18, 23, 30) .
Bordetella pertussis, the causative agent of whooping cough, adheres to the cilia of the upper respiratory tract and multiplies locally in the extracellular space, where it releases a number of toxins that cause the local and systemic damages that lead to the disease (25) . In vitro, B. pertussis has also been shown to invade eukaryotic cells (12, 20, 33) . However, the in vivo role of this intracellular stage is unknown. Immunity to B. pertussis can be acquired after disease or vaccination with whole inactivated bacterial cells. Recently, vaccines containing purified antigens have been tested in animal models and clinical studies (25) . These vaccines contain a chemically detoxified form of pertussis toxin (PT) and other antigens such as filamentous hemagglutinin, the 69-kDa outer membrane protein, and/or the fimbriae. The cellular pertussis vaccine has been classically used as an adjuvant for immunoglobulin E (IgE) induction (24) , and an acellular vaccine has been shown to induce PT-specific IgE in vaccinated children. This adjuvant effect can be obtained also with purified PT (26) .
The nature of the immunity against B. pertussis is not yet known. In spite of the fact that in animal models passive immunization with monoclonal antibodies (MAbs) specific for PT protects against infection with virulent bacteria (37), * Corresponding author.
no correlation between anti-PT antibodies and protection was found during a recent clinical trial (1) . With the aim of investigating the role of the cellular immunity in B. pertussis infection and IgE induction, we generated a number of T-cell clones against PT, the 69-kDa outer membrane protein, and filamentous hemagglutinin. All clones were CD4+ CD8-and proliferated in a specific manner in response to Bordetella antigens presented by autologous antigen-presenting cells (APC) (9, 10) . We studied lymphokine production and the helper and cytotoxic properties of these T-cell clones. Furthermore, we found that they were cytotoxic for APC but unable to induce IgE synthesis.
MATERIALS AND METHODS
Antigens. A nontoxic PT mutant, PT-9K/129G, was used as the antigen in this study. This mutant is enzymatically inactive but maintains intact all of the B-and T-cell epitopes of PT (27, 34, 35) . PT and PT-9K/129G were purified from the culture supernatants of the wild-type strain B. pertussis W28 and the recombinant strain B. pertussis W28 expressing the double mnutant PT-9K/129G by Affi-Gel blue absorption and successive column affinity chromatography with FetuinSepharose (34) . In the experiments with denaturated PT-9K/ 129G, the antigen was resuspended in phosphate-buffered saline and heat inactivated at 100°C for 45 min.
Subunit Si from B. pertussis was expressed in Escherichia coli and fused to the NH2-terminal 98 amino acids of the MS2 polymerase (28) . The fusion protein was partially purified by lysing the bacteria and collecting the inclusion bodies and further purified by electroelution as described previously (4) . Synthetic peptides 27 through 40 and 180 through 194 of subunit S1 were purchased from Novabiochem (Laufelfingen, Switzerland).
Media for cell stimulation and growth. The culture medium was RPMI 1640 (Gibco Laboratories, Paisley, Scotland) supplemented with L-glutamine (2 mM), 1% nonessential amino acids, 1% sodium pyruvate, 50 ,ug of gentamicin per ml, 50 ,uM 2-mercaptoethanol, and 10% heat-inactivated pooled human type AB serum (RPMI-HS) or fetal calf serum (RPMI-FCS). To support the antigen-independent growth of T-cell clones, RPMI-HS was supplemented with 50 U of human recombinant interleukin-2 (IL-2; Hoffman-La Roche, Inc., Nutley, N.J.) per ml.
T-celi clones. Quantitation of IL-4, gamma interferon (IFN--y), and IL-2. Viable T blasts of antigen-specific T-cell clones were extensively washed and incubated at 106 cells per ml in RPMI-FCS in the presence of phorbol myristate acetate (PMA; Sigma Chemical Co., St. Louis, MO) (0.5 ng/ml) and anti-CD3 MAb (OKT3; Ortho Pharmaceutical Corp., Raritan, N.J.) (50 ng/ml) for 24 h or in the presence of mitomycin C (Sigma)-treated autologous EBV-transformed B cells and denatured PT for 12, 24, 36, 48 , and 72 h at 37°C in 5% CO2 humidified atmosphere. The cells were then centrifuged at 400 x g for 10 min; the culture supernatants were collected, filtered through a 0.22-p.m-pore-size filter, and then stored in aliquots at -70°C until used. Since no significant changes in the levels of cytokines after different stimulation periods were found, in this report only the results at 72 h are presented.
For the measurement of IFN--y and IL-4 in the supernatants, the IMRX--y IFN radioimmunoassay (Centocor Inc., Malvern, Pa.) and the Quantikine immunoassay (RD Systems, Minneapolis, Minn.), respectively, were used according to the manufacturers' instructions. IL-2 was determined by testing its effect on the proliferation of the IL-2-dependent T-cell line CTLL, as described elsewhere (22) . Briefly, Measurement of immunoglobulin synthesis. Enriched B-cell suspensions from the peripheral blood of normal donors were prepared as described elsewhere (8, 22) . They usually contained 50 to 70% B cells, 10 to 15% macrophages, and less than 1% T cells, as judged by cytofluorographic analysis with anti-CD20 (Bi; Kontron, Zurich, Switzerland), anti-CD14 MAb (OKT14; Ortho), and anti-CD3 MAb (OKT3; Ortho), respectively. They will be referred as B lymphocytes for simplicity.
The culture system used for the induction of immunoglobulin synthesis was performed in duplicate tubes containing 4 x 105 B cells and 2 x 105 clonal T blasts that had been preactivated by PMA plus anti-CD3 alone or in the presence of 100 U of recombinant IL-4 (2 x 108 U/mg of protein; the kind gift of Glaxo, Verona, Italy) and 5 ,ug of anti-IFN-,y polyclonal antibody (Genzyme, Boston, Mass.) in 1 ml of RPMI-FCS. After 10 days of culture at 37°C in a 5% CO2 humidified atmosphere, supernatants were collected and assayed for their immunoglobulin content. The radioimmunoassay procedure for the measurement of IgG, IgM, and IgE content has been reported in detail elsewhere (8, 22) . RESULTS PT-dependent lysis of autologous EBV B-cell targets by T-cell clones. We have previously described T-cell clones specific for PT generated from peripheral blood of a donor who had suffered from whooping cough in his childhood (9) . Most of these clones were specific for S1, one of the five subunits of PT that has been shown to be highly immunogenic in animal models (37) . The fine specificity of such clones and of clones reactive to other B. pertussis antigens is shown in Table 1 .
The cytotoxic activity of the clones specific for PT was tested against autologous EBV-B cells pulsed overnight with various doses of the nontoxic PT mutant PT-9K/129G. All of the PT-reactive clones lysed target cells preincubated with PT-9K/129G, whereas no killing was observed with clone RR7, which is specific for the 69-kDa protein (Table 2) . Moreover, there was a dose-dependent effect of the antigen on B-cell killing.
Killing of EBV-B cells preincubated with denatured PT-9K/ 129G or the Si subunit. PT is a complex bacterial protein toxin composed of five subunits, designated Si, S2, S3, S4, and S5 (21, 29) . The subunit Si is an enzyme with ADPribosyltransferase activity on GTP-binding proteins located on the membranes of eukaryotic cells. The other subunits form the B oligomer, which binds to the receptors on the cell surface and translocates the Si subunit across the membrane. Both PT and the B oligomer are mitogenic for T lymphocytes in vitro (27) . The mutant PT-9K/129G is devoid of enzymatic activity but retains the mitogenicity of wildtype PT. Therefore, to exclude the possibility that the killing observed was a result of a nonspecific activation of effector T cells, we next performed a series of experiments in which denatured PT-9K/129G or the sole Si subunit was used as the antigen for sensitization of target cells. The results of a representative experiment (Fig. 1) indicate that the T-cell clones were able to recognize and lyse targets preincubated with native PT-9K/129G and, to a lesser extent, those pulsed with the denatured antigen or Si subunit. These findings indicate that the killing observed is not due to the mitogenic effect of native PT-9K1129G on T cells and is specifically directed to the Si subunit.
Fine antigenic specificity of PT-reactive T cells. T lymphocytes recognize an antigen only after some type of metabolic processing by APC that presents denatured proteins or cleaved peptides in association with the relevant MHC molecules (15, 40) . However, short peptides capable of associating directly with the MHC molecule on the surface of the APC may substitute these processed fragments in stimulating an antigen-specific immune response (6) . Using this approach, we preincubated EBV-B target cells with two synthetic peptides homologous to the Si subunit and then tested their susceptibility to killing by the clones T215 and S223. Clone T215 showed strong and specific cytotoxic activity when autologous EBV-B cells were preincubated with either PT-9K/129G or synthetic Si peptide 27-40, whereas no killing was demonstrated with the unrelated peptide [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] (Table 3 ). In contrast, clone S223, which is specific for an epitope not present on the peptides tested, did not cause any lysis of target cells pulsed with the peptides. These results indicate that the killing of Si-sensitized target cells is highly specific, depending on the T-cell epitope recognized.
MHC restriction of antigen-specific T-cell clones. MAbs directed against the nonpolymorphic framework determinants of class I or class II-DR molecules were added to the wells during the assay. The anti-DR MAb significantly inhibited lysis of antigen-pulsed EBV-B cells (Table 4) . Conversely, treatment with the anti-class I MAb did not cause inhibition of cytolysis but sometimes resulted in an increased level of cytotoxicity. These data indicate that the killing is class II DR restricted. It was therefore interesting to investigate whether the restriction element was DR1, as (13, 38) , human helper T (Th) lymphocytes can be divided into at least three different subsets (22) . The first (Thl) is capable of producing IFN-y, IL-2, and tumor necrosis factor; the second (Th2) produces IL-4, IL-5, and IL-6; and the third (ThO) produces IFN-y, IL-4, and IL-2. Moreover, it has been found, in both human and murine systems, that IL-4 is essential for the induction of IgE synthesis, whereas IFN-y exerts an inhibitory effect (7, 8, 32) . Since PT has been reported to increase the levels of IgE in serum during B. pertussis infection (26) and PT vaccination induces PT-specific IgE (17), we investigated the ND ND ND a Cells were stimulated with 50 ng of soluble anti-CD3 per ml and 0.5 ng of PMA per ml for 24 h.
b Clones specific for S1 subunit were stimulated with 3 ,ug of purified holotoxin per ml for 72 h. (Proliferation of the clones was also measured as a control of antigen stimulation.) c ND, not determined.
pattern of lymphokine synthesis and immunoglobulin induction by T-cell clones specific for PT and other B. pertussis antigens. Interestingly, when a potent aspecific stimulus such as PMA plus anti-CD3 MAb was used, all of the clones were able to produce high amounts of IFN-y and IL-2. Two clones (S105 and R2F) also produced significant levels of IL-4 (Table 5 ). However, when PT was used as a specific stimulus, IFN--y, but neither IL-2 nor IL-4, was detected in the supernatant. Whether this is due to the lack of production of these cytokines after antigen stimulation or to consumption by T cells during proliferation remains to be established. In other experiments we have found that T-cell clones unable to secrete detectable amounts of IL-4 usually do not express IL-4 mRNA (31). Induction of immunoglobulin synthesis was investigated by culturing preactivated T cells with allogeneic B lymphocytes purified from the peripheral blood of two donors. As shown in Table 6 , all clones provided help for IgM and IgG but were not able to induce IgE synthesis. Since the addition of exogenous IL-4 in the same experiment induced the synthesis of IgE (Table 6 ), we conclude that our clones are unable to provide help for IgE production. In the same experiment, a clone known to provide help for IgE synthesis, DP18 (31), induced IgE production even in the absence of exogenous IL-4 ( (18) . However, evidence obtained in several experimental systems has challenged this relatively simple scenario (18, 23, 30) . In the human immune response to mycobacteria, it was found, for example, that mycobacterial antigens not only stimulate Th cells to produce macrophage-activating factors but also stimulate CD4+ cytotoxic T lymphocytes, which lyse the human macrophages that harbor the pathogen (16) . Furthermore, CD4+ T-cell clones generated from lymphocytes infiltrating the liver of a patient with chronic hepatitis B showed strong and specific cytotoxicity against autologous B cells preincubated with hepatitis B surface antigen (3 (27, 34) , suggest that the adjuvant effect of PT for IgE production is not due to PT-specific Th cells and therefore should be attributed to intrinsic properties of PT.
In conclusion all of these findings suggest that Th cellmediated immunity may play a crucial role in in vivo infection with B. pertussis.
